A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells - No Study Results Posted

A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells (CHESAT)

This study is ongoing, but not recruiting participants.

Study NCT00703222 Information provided by Baylor College of Medicine

First Received: June 20, 2008 Last Updated: April 13, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2028
Estimated Primary Completion Date:	July 2013 (Final data collection date for primary outcome measure)